CME vs KNSL
CME Group vs Kinsale Capital Group — AI-powered side-by-side comparison
VS
KNSL
Kinsale Capital Group
69
Buy
| Metric | CME | KNSL |
|---|
| AI Score |
63
|
69
|
| Price |
$281.06
|
$387.02
|
| P/E Ratio |
23.40×
|
15.67×
|
| ROE |
14.1%
|
25.7%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
81.9%
|
50.1%
|
| Debt / Equity |
0.13×
|
0.11×
|
| Dividend Yield |
4.1%
|
0.2%
|
| RSI (14) |
68.7
|
62.2
|
| Beta |
0.267
|
0.889
|
| Expected Upside |
+3.7%
|
+8.5%
|
AI Committee View
Current Innellis committee reasoning for CME versus KNSL.
KNSL leads by 6 points.
KNSL scores 69/100 (Buy) versus CME at 63/100 (Buy).
CME Committee View
67% agreement
6 analysts
The primary driver is low leverage (debt-to-equity 0.12) -- balance sheet can absorb a shock. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- ROE of 15.6% shows genuine earnings power backing the valuation — Value
- MACD histogram positive -- bullish momentum — Technical
- Weekly trend (sideways) confirms the daily trend -- multi-timeframe agreement — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
KNSL Committee View
100% agreement
6 analysts
The primary driver is eps growing 28.9% yoy. The main limiting factor is sector concentration is already high (hhi 3079.8). The committee is constructive but not yet at full conviction.
Bull Case
- P/E of 14.9 is inexpensive for the broad market — Value
- ROE of 29.1% shows genuine earnings power backing the valuation — Value
- EPS growing 28.9% YoY — Growth
Bear Case
- Price-to-book of 4.6x prices in significant intangible value — Value
- Weekly RSI at 77 -- overbought on the larger timeframe too — Technical